+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Laryngeal Cancer Therapeutics Market 2021-2025- Product Image

Global Laryngeal Cancer Therapeutics Market 2021-2025

  • ID: 5304719
  • Report
  • February 2021
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Amgen Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • MORE
Global Laryngeal Cancer Therapeutics Market 2021-2025

The publisher has been monitoring the laryngeal cancer therapeutics market and it is poised to grow by $ 635.07 mn during 2021-2025, progressing at a CAGR of 7% during the forecast period. The report on laryngeal cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of laryngeal cancer and growing number of strategic alliances. In addition, increasing prevalence of laryngeal cancer is anticipated to boost the growth of the market as well.

The laryngeal cancer therapeutics market analysis includes type segment and geographical landscapes.

The laryngeal cancer therapeutics market is segmented as below:

By Type
  • Biologics
  • Small molecules
By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the increasing number of reimbursement programs as one of the prime reasons driving the laryngeal cancer therapeutics market growth during the next few years.

The report on laryngeal cancer therapeutics market covers the following areas:
  • Laryngeal cancer therapeutics market sizing
  • Laryngeal cancer therapeutics market forecast
  • Laryngeal cancer therapeutics market industry analysis
The publisher robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading laryngeal cancer therapeutics market vendors that include Amgen Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, and Spectrum Pharmaceuticals Inc. Also, the laryngeal cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Amgen Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Type
  • Market segments
  • Comparison by Type
  • Biologics - Market size and forecast 2020-2025
  • Small molecules - Market size and forecast 2020-2025
  • Market opportunity by Type
Customer landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
  • Competitive scenario
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Amgen Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Sanofi SA
  • Spectrum Pharmaceuticals Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Type - Market share 2020-2025 (%)
  • Comparison by Type
  • Biologics - Market size and forecast 2020-2025 ($ million)
  • Biologics - Year-over-year growth 2020-2025 (%)
  • Small molecules - Market size and forecast 2020-2025 ($ million)
  • Small molecules - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Type
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Amgen Inc. - Overview
  • Amgen Inc. - Business segments
  • Amgen Inc. - Key offerings
  • Amgen Inc. - Key customers
  • Amgen Inc. - Segment focus
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product and service
  • AstraZeneca Plc - Key offerings
  • AstraZeneca Plc - Key customers
  • AstraZeneca Plc - Segment focus
  • Bristol-Myers Squibb Co. - Overview
  • Bristol-Myers Squibb Co. - Product and service
  • Bristol-Myers Squibb Co. - Key offerings
  • Bristol-Myers Squibb Co. - Key customers
  • Bristol-Myers Squibb Co. - Segment focus
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Business segments
  • Eli Lilly and Co. - Key offerings
  • Eli Lilly and Co. - Key customers
  • Eli Lilly and Co. - Segment focus
  • F. Hoffmann-La Roche Ltd. - Overview
  • F. Hoffmann-La Roche Ltd. - Business segments
  • F. Hoffmann-La Roche Ltd. - Key offerings
  • F. Hoffmann-La Roche Ltd. - Key customers
  • F. Hoffmann-La Roche Ltd. - Segment focus
  • Merck & Co. Inc. - Overview
  • Merck & Co. Inc. - Business segments
  • Merck & Co. Inc. - Key offerings
  • Merck & Co. Inc. - Key customers
  • Merck & Co. Inc. - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Regeneron Pharmaceuticals Inc. - Overview
  • Regeneron Pharmaceuticals Inc. - Product and service
  • Regeneron Pharmaceuticals Inc. - Key offerings
  • Regeneron Pharmaceuticals Inc. - Key customers
  • Regeneron Pharmaceuticals Inc. - Segment focus
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key offerings
  • Sanofi SA - Key customers
  • Sanofi SA - Segment focus
  • Spectrum Pharmaceuticals Inc. - Overview
  • Spectrum Pharmaceuticals Inc. - Business segments
  • Spectrum Pharmaceuticals Inc. - Key offerings
  • Spectrum Pharmaceuticals Inc. - Key customers
  • Spectrum Pharmaceuticals Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Amgen Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • MORE
The publisher recognizes the following companies as the key players in the global laryngeal cancer therapeutics market: Amgen Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, and Spectrum Pharmaceuticals Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing number of reimbursement programs.'

According to the report, one of the major drivers for this market is the increasing prevalence of laryngeal cancer.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • Amgen Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Sanofi SA
  • Spectrum Pharmaceuticals Inc.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll